VelvetBarbie

XSPA Our patience is running out and ready for a break out

Long
NASDAQ:XSPA   None
For the past 24 trading days the RSI has been trading in the 20-30 range and yesterday (9/28) is the first day it reached slightly above 40 signaling more confidence than it has in the last month. The volume traded today, Sept. 29 (2.1 million, RSI 41.51) was 3 million less than the day before, Sept. 28 (5.1 million, RSI 44.51) which I am going to assume the bulls shook out the last of the bears. The Bollinger Bands are coming to a squeeze after bouncing around for the whole month of September trading in a tunnel between $1.66-2.12. XSPA needs news... bad. Were tonight's debates about a vaccine enough to push this back above its 50 day trading average of 2.79? XSPA needs GREAT news to push this up 47% so it can begin trading above the 50 DMA, as it has been since August 6 since the last time it traded above the 50 DMA. Current support of 1.66 used to be resistance prior to the news of XSPA contract signing with JFK airport on May 22. The breakout from a bullish flag often results in a powerful move higher, usually measuring the length of the prior flag pole but first this must past resistance (R2) of 2.12. Once this has been achieved, (R3) 3.74, and (R4) 4.74 should soon follow. It is inevitable that business is picking up, people need to travel for work, people WANT a vacation AWAY from home, and airports will forever be accused of being a breeding ground for sickness and disease. There is NO reason XSPA's COVID testing/wellness concept at airports will fail unless it fails internally. Yes, I am a bag holder for now, but you cannot lose if you do not sell. I believe this is a long hold at least until after the election which brings us to holiday travel. If XSPA is operational at all major airports for holiday travelers, just maybe it can break its 52 week high of 8.82
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.